Fu Y - Search Results

1

Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor.

Ling J, Shi L, Cheng X, Fu Y, Lin Z, Zhao Y, Li Z, Zhang J, Hu H, Cai Y, Deng Y. Ling J, et al. Among authors: fu y. J Gastrointest Oncol. 2023 Feb 28;14(1):73-84. doi: 10.21037/jgo-22-931. Epub 2023 Jan 10. J Gastrointest Oncol. 2023. PMID: 36915468 Free PMC article.

2

Clinicopathological, molecular features and prognosis of colorectal cancer with mucinous component.

Li J, Yang L, Bai F, Cai Y, Zhang J, Wu Z, Fu Y, Deng Y. Li J, et al. Among authors: fu y. Future Oncol. 2021 Apr;17(11):1351-1362. doi: 10.2217/fon-2020-1055. Epub 2020 Dec 17. Future Oncol. 2021. PMID: 33331169

3

LncRNA ENSG00000254615 Modulates Proliferation and 5-FU Resistance by Regulating p21 and Cyclin D1 in Colorectal Cancer.

Fu Y, Huang R, Li J, Xie X, Deng Y. Fu Y, et al. Cancer Invest. 2021 Oct;39(9):696-710. doi: 10.1080/07357907.2021.1923727. Epub 2021 Sep 1. Cancer Invest. 2021. PMID: 33938344

4

KLF4 transactivates TRIM29 expression and modulates keratin network.

Huang R, Fu Y, Deng Y. Huang R, et al. Among authors: fu y. Biochem Biophys Rep. 2021 Aug 27;28:101117. doi: 10.1016/j.bbrep.2021.101117. eCollection 2021 Dec. Biochem Biophys Rep. 2021. PMID: 34485714 Free PMC article.

5

Downregulation of FEM1C enhances metastasis and proliferation in colorectal cancer.

Huang R, Li J, Fu Y, Deng Y. Huang R, et al. Among authors: fu y. Ann Transl Med. 2021 Sep;9(17):1391. doi: 10.21037/atm-21-4244. Ann Transl Med. 2021. PMID: 34733943 Free PMC article.

6

Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair-Deficient Colorectal Cancer.

Li J, Hu H, Qin G, Bai F, Wu X, Ke H, Zhang J, Xie Y, Wu Z, Fu Y, Zheng H, Gong L, Xie Z, Deng Y. Li J, et al. Among authors: fu y. Clin Cancer Res. 2024 Jan 17;30(2):368-378. doi: 10.1158/1078-0432.CCR-23-2213. Clin Cancer Res. 2024. PMID: 37906636

7

Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy.

Qin G, Bai F, Hu H, Zhang J, Zhan W, Wu Z, Li J, Fu Y, Deng Y. Qin G, et al. Among authors: fu y. Mol Med. 2024 Jan 20;30(1):13. doi: 10.1186/s10020-024-00780-4. Mol Med. 2024. PMID: 38243170 Free PMC article.

8

Optimized personalized management approach for moderate/severe OHSS: development and prospective validation of an OHSS risk assessment index.

Cao M, Lin Q, Liu Z, Lin Y, Huang Q, Fu Y, Zhang Y, Shi H, Duan C, Liu H, Liu J. Cao M, et al. Among authors: fu y. Hum Reprod. 2024 Oct 1;39(10):2320-2330. doi: 10.1093/humrep/deae197. Hum Reprod. 2024. PMID: 39237109

9

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.

Cai Q, Huang D, Ou P, Yu H, Zhu Z, Xia Z, Su Y, Ma Z, Zhang Y, Li Z, He Q, Liu L, Fu Y, Chen J. Cai Q, et al. Among authors: fu y. Allergy. 2020 Jul;75(7):1742-1752. doi: 10.1111/all.14309. Epub 2020 Apr 17. Allergy. 2020. PMID: 32239761

10

Application of extracorporeal carbon dioxide removal combined with continuous blood purification therapy in ARDS with hypercapnia in patients with critical COVID-19.

Chen Y, Wang S, Huang J, Fu Y, Wen J, Zhou C, Fu Y, Liu L. Chen Y, et al. Among authors: fu y. Clin Hemorheol Microcirc. 2021;78(2):199-207. doi: 10.3233/CH-201080. Clin Hemorheol Microcirc. 2021. PMID: 33554895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,381 results

Search Page

Filters